Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Informed consent and tardive dyskinesia.

I Kleinman1, D Schachter, E Koritar

  • 1Department of Psychiatry, Mount Sinai Hospital, Toronto, Ont., Canada.

The American Journal of Psychiatry
|July 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obtaining informed consent of patients at risk of neuroleptic malignant syndrome.

Psychiatric services (Washington, D.C.)·2000
Same author

Eyelid resurfacing.

Lasers in surgery and medicine·1999
Same author

Guidelines for the psychotherapies in comprehensive psychiatric care: a discussion paper. Working Group 2 of the Canadian Psychiatric Association Psychotherapies Steering Committee.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·1999
Same author

Informed consent for antipsychotic medication.

Canadian family physician Medecin de famille canadien·1999
Same author

Psychiatrists' documentation of informed consent.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·1998
Same author

Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts.

Transplantation·1998

Formalized patient education effectively improved knowledge of neuroleptic medication risks, like tardive dyskinesia, in schizophrenia patients. This process showed no negative impact on psychiatric admissions or medication adherence.

Area of Science:

  • Psychiatry
  • Clinical Pharmacology

Background:

  • Neuroleptic medications are crucial for managing schizophrenia.
  • Patient understanding of medication risks, such as tardive dyskinesia, is vital for adherence and informed consent.

Purpose of the Study:

  • To assess the effectiveness of a formalized informing process in educating stable schizophrenic outpatients about neuroleptic medication risks and benefits.
  • To evaluate the impact of this education on knowledge of tardive dyskinesia.

Main Methods:

  • A multiple-choice questionnaire was administered to assess patient knowledge.
  • Two groups were compared: 21 patients who received standardized information and 27 who did not.
  • Knowledge scores were compared between groups and at a 6-month follow-up.
Keywords:
Empirical ApproachMental Health TherapiesProfessional Patient RelationshipTardive Dyskinesia

Related Experiment Videos

Main Results:

  • Patients who received the standardized information demonstrated significantly higher knowledge scores compared to the control group.
  • This knowledge improvement was sustained at the 6-month follow-up.
  • The informing process did not adversely affect psychiatric admission rates, medication compliance, or the need for increased antipsychotic medication.

Conclusions:

  • A formalized informing process is an effective method for enhancing patient knowledge regarding neuroleptic medication risks and benefits.
  • This educational intervention is safe and does not negatively impact clinical outcomes in stable schizophrenic outpatients.
  • Improved patient understanding can be achieved without compromising treatment adherence or stability.